Denemek ALTIN - Özgür

TRANSFORMING PATIENT CARE USING DATA ANALYTICS

Healthcare Radius

|

August 2025

The future of healthcare will be defined by smarter medicine, data-driven decision making and risk prediction, and personalized treatment.

- By Shashank Silhare, Engagement Partner, Practus

TRANSFORMING PATIENT CARE USING DATA ANALYTICS

What is the most valuable asset in the world we live in? I am sure many of you answered “data” without blinking an eye. Traditionally, the healthcare industry has had a linear and reactive approach - a patient would walk in with symptoms, a diagnosis would be made, and the treatment would follow. However, with advancements in data analytics, a shift towards personalized and predictive system has been seen.

The data analytics market is expected to grow to USD 94.86 billion in 2025, from USD 74.83 billion in 2024, at a CAGR of 26.8%. Truly, the impact of data on any sector, industry, or walk of life is undeniable. Patient care is no exception.

Data and analytics can help in creating personalized and tailored treatment plans, making patients more empowered, identifying and addressing future outcomes, and streamlining healthcare operations for efficiency and accuracy.

Personalized and Tailored Medicine

Consider an instance where two patients present with the same diagnosis of Type 2 diabetes. Traditionally, the same treatment and medication would have been prescribed for both. But now, with data analytics, the healthcare providers can gauge that one patient responds better to a specific medication due to a genetic variant, while the other does better with lifestyle modifications. This is personalized treatment or precision medicine - the practice of crafting treatment plans that are uniquely suited to an individual's genetic makeup, lifestyle, and health history.

Empowering Patients with Information

Healthcare Radius'den DAHA FAZLA HİKAYE

Healthcare Radius

Healthcare Radius

VENUS REMEDIES GETS DRUG APPROVALS IN VIETNAM

Venus Remedies, a fixed-dosage injectable manufacturer, has secured new marketing authorisations for Methotrexate, Cefuroxime, and Irinotecan in Vietnam.

time to read

1 mins

December 2025

Healthcare Radius

Healthcare Radius

A HEALTHIER INDIA IN THE MAKING: LEADERS DECODE THE ROAD FROM 2025 TO 2026

The collective goal is clear and unanimous: to transition from a system that primarily treats sickness to one that actively promotes lifelong health and well-being.

time to read

12 mins

December 2025

Healthcare Radius

Healthcare Radius

FROM GENES TO CARE: ADVANCING CLINICAL UNDERSTANDING OF HYPOPHOSPHATASIA

From genes to care, the story of hypophosphatasia reminds us that progress in medicine isn't only about scientific discovery, it's about turning knowledge into healing.

time to read

6 mins

December 2025

Healthcare Radius

ALEMBIC PHARMA GETS USFDA NOD FOR DILTIAZEM TABLETS IN THE US

Alembic Pharmaceuticals (Alembic) Aamour announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

ZYDUS GETS USFDA APPROVAL FOR PROSTATE CANCER INJECTABLE

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial (USRLD: Lupron Injection®, 1 mg/0.2 mL).

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

SUPERHEALTH LAUNCHES HONEST SECOND OPINION FOR PATIENTS

Superhealth, a zero-wait, commission Superhealth, zerohospital network, announced the launch of \"Honest Second Opinion,\" a service that helps patients make informed decisions about their treatment plans and surgical recommendations.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

KOTAK ALTS INVESTS RS 400MN IN MEDIVERSAL

Kotak Alternate Asset Managers (Kotak Alts), through its Kotak Life Science Fund I, which invests in early to growth-stage life sciences and healthcare businesses, has made an investment of Rs 400 million in Mediversal Healthcare.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

INVIGA HEALTHCARE FUND ACQUIRES 21% STAKE IN FORUS HEALTH

Inviga Healthcare Fund (IHF), the private equity platform founded by Dr B. S. Ajaikumar of HCG, has acquired a 21 per cent stake in Forus Health, an ophthalmic diagnostics company whose devices have screened over 22 million patients across 75+ countries.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

OPTIMISING MATERNITY OPS: REDUCING C-SECTION BURDEN THROUGH EVIDENCE-BASED PROTOCOLS

By building systems that support safety, documentation, and respectful care, institutions can improve outcomes, lower litigation risks, and strengthen quality scores, achieving what healthcare should truly represent: Care Through Trust.”

time to read

7 mins

December 2025

Healthcare Radius

Healthcare Radius

MENTAL HEALTH CARE GOES DIGITAL WITH NEW THERAPY PLATFORM

Following the global observance and continuing the commitment to mental well-being, renowned clinical psychologist Kanika Jindal announced the launch of Harmony Therapy World, a holistic digital platform designed to bring emotional healing and psychological support to people everywhere, privately, compassionately, and without barriers.

time to read

1 min

December 2025

Listen

Translate

Share

-
+

Change font size